Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP
Completed · Not applicable · Has a placebo group
Conditions studied: Non-Specific Chronic Lower Back Pain
In brief
This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.
Key facts
- Study ID
- NCT05972889
- Run by
- Zynex Medical, Inc.
- People needed
- 334
- Starts
- 2023-11-02
- Expected to finish
- 2025-10-21
- Last updated by the study team
- 2025-10-28
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ages 18-70, or older if specified by law
- Non-specific chronic lower back pain defined as:
- Having lasted ≥3 months in duration
- Current Visual Analogue Scale (VAS) pain rating ≥50 out of 100 (or an equivalent of 5 out of 10 on a 10-point scale)
- No radiating pain below the knee
- ≥75% back or buttock pain rather than lower extremity pain
- Subjects who are willing and capable of providing informed consent
- Subjects who are willing and capable of participating in all testing and questionnaire requirements associated with the clinical study
You may not qualify if…
- Any prior home use of the NexWave or any TENS/IFC device
- Any history of lumbar spine surgery or spinal fractures
- Subjects with a history of rheumatic disease
- Subjects with spine disorders, deformities, or severe spinal conditions such as scoliosis and kyphosis, Pott's disease, disc protrusion, or others that can be attributed to specific causes of back pain
- Subjects currently prescribed and adherent to opioid therapy
- Current implanted cardiac pacemakers, defibrillators, cardiac pumps, spinal stimulators, or other implanted electronic devices
- Active psychiatric or uncontrolled mood disorders including subjects on antipsychotic medication, diagnosis of bipolar disorder or schizophrenia, or uncontrolled anxiety or clinical depression
- Subjects with a known history of allergic reactions to medical adhesives or any condition that could affect placement of the electrodes
- Women of childbearing potential who are pregnant or who are planning to become pregnant during the anticipated study period
- Subjects with health conditions that in the Investigator's medical opinion would prevent participation in the study, interfere with assessment or therapy, significantly raise the risk of study participation, or modify outcome data or its interpretation
- Subjects who are currently enrolled in another investigational study that would directly interfere with the current study
Where it is running
- DBPS Research — Greenwood Village, Colorado, United States
- McGreevy NeuroHealth — Saint Augustine, Florida, United States
- Peachtree Orthopedics — Atlanta, Georgia, United States
- Horizon Clinical Research — Jasper, Georgia, United States
- Applied Pain Institute, LLC — Bloomington, Illinois, United States
- One Oak Medical — Congers, New York, United States
- The Center for Clinical Research, LLC — Winston-Salem, North Carolina, United States
- Summit Brain, Spine and Orthopedics — Lehi, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.